Electrical storm in a patient with Charcot-Marie-Tooth disease treated with radiofrequency ablation and subsequent serious complication of implantable cardioverter defibrillator implantation: a case report
Status PubMed-not-MEDLINE Jazyk angličtina Země Anglie, Velká Británie Médium electronic-ecollection
Typ dokumentu kazuistiky, časopisecké články
PubMed
39748939
PubMed Central
PMC11694671
DOI
10.1093/ehjcr/ytae673
PII: ytae673
Knihovny.cz E-zdroje
- Klíčová slova
- Case report, Charcot–Marie–Tooth, Electric storm, ICD, Ventricular tachycardia,
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
BACKGROUND: Charcot-Marie-Tooth is the most common inherited neuromuscular disorder. Rarely, it can be associated with heart failure and various arrhythmic disturbances. This case illustrates the challenges of making decisions to prevent sudden cardiac death in a patient with Charcot-Marie-Tooth disease. CASE SUMMARY: A 69-year-old male with a history of Type 1A Charcot-Marie-Tooth disease was admitted due to repetitive runs of ventricular tachycardia. Twelve-lead electrocardiogram, echocardiography, selective coronary angiography, and cardiac magnetic resonance did not clarify the cause of the electrical storm. As conservative therapy was not successful, radiofrequency ablation was chosen to treat the electrical storm. After this procedure, implantable cardioverter defibrillator (ICD) was implanted. The follow-up revealed severe perforation by the ventricular lead. An extraction was performed with no complications and a new lead was immediately implanted. The patient remains asymptomatic. Three episodes of non-sustained ventricular tachycardia were recorded during the last follow-up. DISCUSSION: This case illustrates the challenges of making decisions to prevent sudden cardiac death in a patient with Charcot-Marie-Tooth disease after successful ablation for electrical storm. Due to a lack of evidence, atypical origin of arrhythmia, and clinical presentation, we did not consider this as idiopathic arrhythmia and decided to implant an ICD, which was complicated by severe perforation by the lead. Specific recommendations for preventing sudden cardiac death in rare cardiac conditions, such as Charcot-Marie-Tooth disease, still need to be refined.
Zobrazit více v PubMed
Morena J, Gupta A, Hoyle JC. Charcot–Marie–Tooth: from molecules to therapy. Int J Mol Sci 2019;20:3419. PubMed PMC
Okamoto Y, Takashima H. The current state of Charcot–Marie–Tooth disease treatment. Genes (Basel) 2023;14:1391. PubMed PMC
Pareyson D, Marchesi C. Diagnosis, natural history, and management of Charcot–Marie–Tooth disease. Lancet Neurol 2009;8:654–667. PubMed
Battistella PA, Moreolo GS, Benetti E, Da Dalt L, Pellegrino PA. Charcot–Marie–Tooth disease and cardiac arrhythmias. Brain Dev 1988;10:262–263. PubMed
Vrtal J, Plášek J. Electrical storm in a patient with Charcot–Marie–Tooth disease treated with radiofrequency ablation and subsequent serious complication of ICD implantation. Retrieved October 1, 2024. https://esc365.escardio.org/presentation/287458.2024. PubMed PMC
Eltawansy SA, Bakos A, Checton J. Noncompaction cardiomyopathy with Charcot–Marie–Tooth disease. Case Rep Cardiol 2015;2015:646890. PubMed PMC
Tetzlaff JE, Schwendt I. Arrhythmia and Charcot–Marie–Tooth disease during anesthesia. Can J Anaesth 2000;47:829. PubMed
Corrado G, Checcarelli N, Santarone M, Stollberger C, Finsterer J. Left ventricular hypertrabeculation/noncompaction with PMP22 duplication-based Charcot–Marie–Tooth disease Type 1A. Cardiology 2006;105:142–145. PubMed
Benedetti S, Bertini E, Iannaccone S, Angelini C, Trisciani M, Toniolo D, et al. Dominant LMNA mutations can cause combined muscular dystrophy and peripheral neuropathy. J Neurol Neurosurg Psychiatry 2005;76:1019–1021. PubMed PMC
Liang JJ, Grogan M, Ackerman MJ, Goodsell K. LMNA-mediated arrhythmogenic right ventricular cardiomyopathy and Charcot–Marie–Tooth Type 2B1: a patient-discovered unifying diagnosis. J Cardiovasc Electrophysiol 2016;27:868–871. PubMed
Yerabandi N, Kouznetsova VL, Kesari S, Tsigelny IF. The role of BAG3 in dilated cardiomyopathy and its association with Charcot–Marie–Tooth disease Type 2. Acta Myol 2022;41:59–75. PubMed PMC
Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, et al. 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2022;43:3997–4126. PubMed